Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chief Executive Officer of RESMED INC. Currently has a direct ownership of 455,472 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 11, 2024, when has been sold 8,779 shares (ResMed Common Stock) at a price of $252.38 per share, resulting in proceeds of $2,215,644. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 455K

1.87% 3M change

3.84% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Payment of exercise price or tax liability	$2,215,644 $252.38 p/Share	8,779 Reduced 1.89%	455,472 ResMed Common Stock
Nov 07 2024	SELL Open market or private sale	$3,615,835 $246.26 p/Share	14,683 Reduced 3.07%	464,254 ResMed Common Stock
Nov 07 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 2.97%	478,937 ResMed Common Stock
Oct 07 2024	SELL Open market or private sale	$3,405,134 $231.91 p/Share	14,683 Reduced 3.07%	464,169 ResMed Common Stock
Oct 07 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 2.98%	478,852 ResMed Common Stock
Sep 09 2024	SELL Open market or private sale	$3,646,963 $248.38 p/Share	14,683 Reduced 3.07%	464,169 ResMed Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 2.98%	478,852 ResMed Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	23,370 Added 4.79%	464,169 ResMed Common Stock
Aug 07 2024	SELL Open market or private sale	$3,145,832 $214.25 p/Share	14,683 Reduced 3.22%	440,799 ResMed Common Stock
Aug 07 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 3.12%	455,482 ResMed Common Stock
Jul 08 2024	SELL Open market or private sale	$2,833,378 $192.97 p/Share	14,683 Reduced 3.22%	440,799 ResMed Common Stock
Jul 08 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 3.12%	455,482 ResMed Common Stock
Jun 07 2024	SELL Open market or private sale	$3,107,803 $211.66 p/Share	14,683 Reduced 3.22%	440,799 ResMed Common Stock
Jun 07 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 3.12%	455,482 ResMed Common Stock
May 07 2024	SELL Open market or private sale	$3,178,869 $216.5 p/Share	14,683 Reduced 3.22%	440,752 ResMed Common Stock
May 07 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 3.12%	455,435 ResMed Common Stock
Nov 20 2023	SELL Payment of exercise price or tax liability	$350,306 $148.94 p/Share	2,352 Reduced 0.53%	438,633 ResMed Common Stock
Nov 15 2023	SELL Open market or private sale	$863,283 $152.04 p/Share	5,678 Reduced 1.27%	440,986 ResMed Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$327,961 $57.76 p/Share	5,678 Added 1.26%	446,664 ResMed Common Stock
Nov 13 2023	SELL Payment of exercise price or tax liability	$1,213,420 $143.6 p/Share	8,450 Reduced 1.88%	440,986 ResMed Common Stock
Oct 16 2023	SELL Open market or private sale	$798,472 $140.7 p/Share	5,675 Reduced 1.25%	449,360 ResMed Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.23%	455,035 ResMed Common Stock
Sep 15 2023	SELL Open market or private sale	$830,536 $146.35 p/Share	5,675 Reduced 1.25%	449,360 ResMed Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.23%	455,035 ResMed Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	12,430 Added 2.69%	449,360 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

MJF